1001-6821
2014 Issue 10
Study on efficacy and safety of sildenafil for the treatment of pulmonary arterial hypertension
LI Wei;,WANG Jing;,XIA Yu;,YAN Fang;
LI Wei;,WANG Jing;,XIA Yu;,YAN Fang;
..............page:877-879
Effect of carvedilol combined with telmisartan on refractory hypertension and its influence on glucose and lipid metabolism
SUN Shu-ping;
SUN Shu-ping;
..............page:880-882
Clinical study of irbesartan and atorvastatin on paroxysmal atrial fibrillation of patients with essential hypertension
LU Li-ping;,MA Yu-ling;,WANG Gang;,WANG Mei-jian;
LU Li-ping;,MA Yu-ling;,WANG Gang;,WANG Mei-jian;
..............page:883-885
Evaluation on the efficacy of ulinastatin on inflammation levels of acute lung injury patients after trauma and its clinical significance
WANG Hui;,ZHANG Jian;
WANG Hui;,ZHANG Jian;
..............page:886-888
Clinical curative effect and safety analysis of insulin glargine and acarbose treatment in elderly diabetes patients
RUAN Ling-yan;,WANG Xiao-jing;,ZHOU Xiao-ai;
RUAN Ling-yan;,WANG Xiao-jing;,ZHOU Xiao-ai;
..............page:889-891
Clinical observation of rat nerve growth factor combined with αlipoic acid for treatment of diabetic peripheral neuropathy
CHEN Ri-qiu;,DING Li;,GUAN Chang-rong;,ZHU Ying-biao;
CHEN Ri-qiu;,DING Li;,GUAN Chang-rong;,ZHU Ying-biao;
..............page:892-894,900
Clinical effects of tripterygium glycosides in treatment of children with henoch -schonlein prupura nephritis and its influence on immunologic function
HUANGFU Chun-rong;,LI Ping;,TANG Chun-hui;
HUANGFU Chun-rong;,LI Ping;,TANG Chun-hui;
..............page:895-897
Relationship between k -RAS mutation and resistance to gefinitib treatment in patients with non -small -cell lung cancer
GU Liang;,WU Wen-juan;
GU Liang;,WU Wen-juan;
..............page:898-900
Clinical study of docetaxel plus cisplatin regimen combined with parenteral enteral nutrition on the treatment of gastric cancer
CHEN Bei-bei;,CHEN Xiao-bing;,HUANG Jin-xi;,WANG Cheng-hu;,YANG Tie-jun;,YUAN Wei-wei;,ZHOU Yi;
CHEN Bei-bei;,CHEN Xiao-bing;,HUANG Jin-xi;,WANG Cheng-hu;,YANG Tie-jun;,YUAN Wei-wei;,ZHOU Yi;
..............page:901-903
Clinical study of thalidomide plus oxaliplatin and capetitabine chemotherapy regimen in the treatment of metastatic colorectal cancer
WEI Zhen;,ZHANG Zhi-xiang;
WEI Zhen;,ZHANG Zhi-xiang;
..............page:904-906
Efficacy and safety of oxaliplatin or irinotecan combined with capecitabine in the treatment of metastasis colorectal carcinoma
LIU Chong-yuan;,LV Lu-min;,XU Bao-kang;
LIU Chong-yuan;,LV Lu-min;,XU Bao-kang;
..............page:907-908,918
Clinical safety study of Menggenwusu -18 pill on psoriasis patients
BATU Deligen;,HAN Zhi-qiang;,QING Yu;,WU Yun;
BATU Deligen;,HAN Zhi-qiang;,QING Yu;,WU Yun;
..............page:909-911
PhaseⅠclinical tolerance study of Picika oral solution in healthy volunteers
BI Jing-feng;,CHEN Ben-chao;,CHEN Zhen;,CHU Yan-yan;,DUAN Feng;,JIN Cheng;,LI Wen-shu;,SUN Bin;,WANG Min;,WEI Zhen-man;,ZHANG Li;,ZHANG Yu;,ZHU Zhen-zhen;
BI Jing-feng;,CHEN Ben-chao;,CHEN Zhen;,CHU Yan-yan;,DUAN Feng;,JIN Cheng;,LI Wen-shu;,SUN Bin;,WANG Min;,WEI Zhen-man;,ZHANG Li;,ZHANG Yu;,ZHU Zhen-zhen;
..............page:912-914
Pharmacokinetics of multiple doses ampiroxicam in Chinese healthy subjects
KANG Zi-sheng;,LIU Yan;,LV Yuan;,WEI Min-ji;,ZHANG Man;,ZHAO Cai-yun;
KANG Zi-sheng;,LIU Yan;,LV Yuan;,WEI Min-ji;,ZHANG Man;,ZHAO Cai-yun;
..............page:915-918
Analysis on the resistance of clinically cefoxitin -non -susceptible Klebsiella pneumoniae isolates and prevalence of β-lactamase
CAO Xiao-li;,LV Yuan;,NING Ming-zhe;,SHEN Han;,XU Xue-jing;,ZHANG Kui;,ZHANG Zhi-feng;,ZHENG Bo;,ZHOU Wan-qing;
CAO Xiao-li;,LV Yuan;,NING Ming-zhe;,SHEN Han;,XU Xue-jing;,ZHANG Kui;,ZHANG Zhi-feng;,ZHENG Bo;,ZHOU Wan-qing;
..............page:919-921
Methodology on construction of rat aldehyde dehydrogenase 2 gene regulation recombinant adenovirus vectors
LANG Xiao-e;,LI Hong-bo;
LANG Xiao-e;,LI Hong-bo;
..............page:922-925
Expression of a disintegrin and metalloprotease 8 during the drug -induced liver in mice
CUI Xu-hong;,HAN Hong-mei;,LI San-qiang;,MA Zhao;,YANG Lan-ze;
CUI Xu-hong;,HAN Hong-mei;,LI San-qiang;,MA Zhao;,YANG Lan-ze;
..............page:926-928
Effect and its mechanism of FoxO3a activates FasL on renal tubular epithelial cell apoptosis induced by renal ischemia/reperfusion injury
DONG Hong-yan;,HU Shu-qun;,JI Huai-xue;,REN Ling;,WANG Yan;,XU Jian;
DONG Hong-yan;,HU Shu-qun;,JI Huai-xue;,REN Ling;,WANG Yan;,XU Jian;
..............page:929-931
Experimental study of effect of amiodarone dosage levels or gender and those interaction on thyroid function in rats
CHEN Shan-jiang;,JIANG Li-qin;,ZHAO Sheng-gang;
CHEN Shan-jiang;,JIANG Li-qin;,ZHAO Sheng-gang;
..............page:932-935
Study on effects of Sini San on the sleeping phase in rats
LI Yue-feng;,XU Fu-ju;,YAN Xing-ke;,ZHANG Ze-guo;
LI Yue-feng;,XU Fu-ju;,YAN Xing-ke;,ZHANG Ze-guo;
..............page:936-938
Study on the stability of cefazolin sodium pentahydrate
CHU Yang;,JIANG Ming-yan;,JIANG Yan;,LUO Yi-fan;
CHU Yang;,JIANG Ming-yan;,JIANG Yan;,LUO Yi-fan;
..............page:939-941,973
Cross -sectional study on drug patterns of mental disorder in Hebei province
JIA Hai-ling;,LI Ke-qing;,SUN Xiu-li;,WANG Jian;,XU Na;,ZHANG Ping;,ZHANG Yun-shu;
JIA Hai-ling;,LI Ke-qing;,SUN Xiu-li;,WANG Jian;,XU Na;,ZHANG Ping;,ZHANG Yun-shu;
..............page:942-945
Characters of coronary disease in young female with coronary heart disease and the treatment analysis
DANG Ai-min;,GAO Li-jian;,YANG Yue-jin;,ZHANG Hai-hua;,ZHANG Yun;
DANG Ai-min;,GAO Li-jian;,YANG Yue-jin;,ZHANG Hai-hua;,ZHANG Yun;
..............page:946-948
Preoperative adjuvant GP chemotherapy regimen vs DP chemotherapy regimen in the treatment of non -small cell lung cancer
FANG Wei-jun;,PAN Feng-jun;,TIAN Wei-qiang;,WU Xiao-fen;,YU Guang-mao;
FANG Wei-jun;,PAN Feng-jun;,TIAN Wei-qiang;,WU Xiao-fen;,YU Guang-mao;
..............page:949-951
Analysis on adverse drug reactions of lenalidomide
HUANG Ze-ping;,LIU Chun-yan;
HUANG Ze-ping;,LIU Chun-yan;
..............page:952-954
Progress in effects of Roux -en -Y gastric bypass surgery on pharmacokinetics of some kinds of common drugs
HE Xiao-jing;,JIAN Ling-yan;
HE Xiao-jing;,JIAN Ling-yan;
..............page:955-957
Sorafenib on clinical application and drug interaction
LI Wen-zhe;,QIU Xiang-jun;,WANG Zhong-hui;,YANG Yue;,ZHAN Hui;,ZHAO Jian-long;
LI Wen-zhe;,QIU Xiang-jun;,WANG Zhong-hui;,YANG Yue;,ZHAN Hui;,ZHAO Jian-long;
..............page:958-961
..............page:962-965
..............page:965-965
Discussions on the standardized safety evaluation of new drugs in phase I clinical trials
GUO Xu-guang;,WANG Shui-qiang;,WEI Min-ji;,ZHAO Cai-yun;
GUO Xu-guang;,WANG Shui-qiang;,WEI Min-ji;,ZHAO Cai-yun;
..............page:966-969
Consideration about the maximum concentration confidence interval limits in the assessment of bioequivalence
WEI Min-Ji;,XIE Song-mei;,YANG Jin;,ZHAO Ming;
WEI Min-Ji;,XIE Song-mei;,YANG Jin;,ZHAO Ming;
..............page:970-973
Interpretation of the guidance of stability testing of drug substances and products
HE Wu;,HUO Xiu-min;,MA Yu-nan;,WEI Nong-nong;
HE Wu;,HUO Xiu-min;,MA Yu-nan;,WEI Nong-nong;
..............page:974-978